EG18104A - Imidazoquinoline antithrombogenic cardiotonic agent - Google Patents

Imidazoquinoline antithrombogenic cardiotonic agent

Info

Publication number: EG18104A
Authority: EG; Egypt
Prior art keywords: imidazoquinoline; antithrombogenic; cardiotonic agent; cardiotonic; agent
Prior art date: 1985-04-25

Application number

EG237/86A

Other languages

English (en)

Original Assignee

Bristol Myers Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-04-25

Filing date

1986-04-23

Publication date

1992-09-30

1986-04-23 Application filed by Bristol Myers Co filed Critical Bristol Myers Co

1992-09-30 Application granted granted Critical

1992-09-30 Publication of EG18104A publication Critical patent/EG18104A/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

EG237/86A 1985-04-25 1986-04-23 Imidazoquinoline antithrombogenic cardiotonic agent EG18104A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72686985A	1985-04-25	1985-04-25
US06/832,212 US4668686A (en)	1985-04-25	1986-02-26	Imidazoquinoline antithrombrogenic cardiotonic agents

Publications (1)

Publication Number	Publication Date
EG18104A true EG18104A (en)	1992-09-30

Family

ID=27111398

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG237/86A EG18104A (en)	1985-04-25	1986-04-23	Imidazoquinoline antithrombogenic cardiotonic agent

Country Status (32)

Country	Link
US (1)	US4668686A (fi)
KR (1)	KR940000828B1 (fi)
CN (1)	CN1016175B (fi)
AT (1)	AT390257B (fi)
AU (1)	AU592983B2 (fi)
BE (1)	BE904671A (fi)
CA (1)	CA1298836C (fi)
CH (1)	CH675722A5 (fi)
CY (1)	CY1641A (fi)
DE (1)	DE3614132A1 (fi)
DK (3)	DK164868C (fi)
EG (1)	EG18104A (fi)
ES (3)	ES8708229A1 (fi)
FI (1)	FI83316C (fi)
FR (1)	FR2581065B1 (fi)
GB (1)	GB2174987B (fi)
GR (1)	GR861086B (fi)
HK (1)	HK64492A (fi)
HU (1)	HU195813B (fi)
IL (1)	IL78581A0 (fi)
IT (1)	IT1215651B (fi)
LU (1)	LU86406A1 (fi)
MY (1)	MY102086A (fi)
NL (1)	NL8601053A (fi)
NO (1)	NO163406C (fi)
NZ (1)	NZ215885A (fi)
OA (1)	OA08242A (fi)
PT (1)	PT82460B (fi)
SE (1)	SE461468B (fi)
SG (1)	SG29092G (fi)
SU (3)	SU1450746A3 (fi)
YU (1)	YU46054B (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4775674A (en) *	1986-05-23	1988-10-04	Bristol-Myers Company	Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) *	1986-07-08	1987-10-20	Bristol-Myers Company	7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4743607A (en) *	1987-05-29	1988-05-10	Merrell Dow Pharmaceuticals Inc.	Cardiotonic tricyclic imidazolones
US4803210A (en) *	1987-05-29	1989-02-07	Merrell Dow Pharmaceuticals Inc.	Cardiotonic tricyclic oxazolones
US4943573A (en) *	1989-11-01	1990-07-24	Bristol-Myers Squibb Company	Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DE4035854C2 (de) *	1990-11-10	1996-10-02	Daimler Benz Ag	Vorrichtung zum Fangen und Ableiten des von einem Fahrzeugrad hochgeschleuderten Spritzwassers
PH31245A (en) *	1991-10-30	1998-06-18	Janssen Pharmaceutica Nv	1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5552267A (en) *	1992-04-03	1996-09-03	The Trustees Of Columbia University In The City Of New York	Solution for prolonged organ preservation
US5348960A (en) *	1992-04-03	1994-09-20	Bristol-Myers Squibb Company	Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5158958A (en) *	1992-04-03	1992-10-27	Bristol-Myers Squibb Company	Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5196428A (en) *	1992-04-03	1993-03-23	Bristol-Myers Squibb Company	Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5208237A (en) *	1992-04-03	1993-05-04	Bristol-Meyers Squibb Company	7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
AU2004266658A1 (en)	2003-08-12	2005-03-03	3M Innovative Properties Company	Hydroxylamine substituted imidazo-containing compounds
KR101106812B1 (ko)	2003-08-27	2012-01-19	쓰리엠 이노베이티브 프로퍼티즈 컴파니	아릴옥시 및 아릴알킬렌옥시 치환된 이미다조퀴놀린
EP1660026A4 (en)	2003-09-05	2008-07-16	3M Innovative Properties Co	TREATMENT FOR CD5 + B CELL LYMPHOMA
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
JP5043435B2 (ja)	2003-10-03	2012-10-10	スリーエムイノベイティブプロパティズカンパニー	アルコキシ置換イミダゾキノリン
EP1685129A4 (en)	2003-11-14	2008-10-22	3M Innovative Properties Co	OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
JP2007511535A (ja) *	2003-11-14	2007-05-10	スリーエムイノベイティブプロパティズカンパニー	ヒドロキシルアミン置換イミダゾ環化合物
WO2005051317A2 (en)	2003-11-25	2005-06-09	3M Innovative Properties Company	Substituted imidazo ring systems and methods
US8802853B2 (en)	2003-12-29	2014-08-12	3M Innovative Properties Company	Arylalkenyl and arylalkynyl substituted imidazoquinolines
JP2007517044A (ja)	2003-12-30	2007-06-28	スリーエムイノベイティブプロパティズカンパニー	イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド
WO2005094531A2 (en)	2004-03-24	2005-10-13	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en)	2004-06-15	2011-09-13	3M Innovative Properties Company	Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8026366B2 (en)	2004-06-18	2011-09-27	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7897609B2 (en)	2004-06-18	2011-03-01	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
WO2006065280A2 (en)	2004-06-18	2006-06-22	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US7943609B2 (en)	2004-12-30	2011-05-17	3M Innovative Proprerties Company	Chiral fused [1,2]imidazo[4,5-C] ring compounds
WO2006083440A2 (en)	2004-12-30	2006-08-10	3M Innovative Properties Company	Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2597092A1 (en)	2005-02-04	2006-08-10	Coley Pharmaceutical Group, Inc.	Aqueous gel formulations containing immune reponse modifiers
EP1846405A2 (en)	2005-02-11	2007-10-24	3M Innovative Properties Company	Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
CA2602590A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
JP2008535832A (ja)	2005-04-01	2008-09-04	コーリーファーマシューティカルグループ，インコーポレイテッド	ピラゾロピリジン−１，４−ジアミン、およびそのアナログ
US7906506B2 (en)	2006-07-12	2011-03-15	3M Innovative Properties Company	Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US8227603B2 (en)	2006-08-01	2012-07-24	Cytokinetics, Inc.	Modulating skeletal muscle
ES2439590T3 (es)	2006-08-02	2014-01-23	Cytokinetics, Inc.	Ciertas entidades químicas, composiciones y métodos
US8299248B2 (en)	2006-08-02	2012-10-30	Cytokinetics, Incorporated	Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
WO2008121333A1 (en)	2007-03-30	2008-10-09	Cytokinetics, Incorporated	Certain chemical entities, compositions and methods
CA2849213A1 (en)	2011-07-13	2013-01-17	Cytokinetics, Inc.	Combination of riluzole and ck-2017357 for treating als

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3932407A (en) *	1973-11-19	1976-01-13	Bristol-Myers Company	Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

1986
- 1986-02-26 US US06/832,212 patent/US4668686A/en not_active Expired - Fee Related
- 1986-03-26 CA CA000505136A patent/CA1298836C/en not_active Expired - Fee Related
- 1986-04-18 NZ NZ215885A patent/NZ215885A/xx unknown
- 1986-04-21 AU AU56413/86A patent/AU592983B2/en not_active Ceased
- 1986-04-22 FI FI861684A patent/FI83316C/fi not_active IP Right Cessation
- 1986-04-22 IL IL78581A patent/IL78581A0/xx not_active IP Right Cessation
- 1986-04-23 EG EG237/86A patent/EG18104A/xx active
- 1986-04-23 CN CN86102747A patent/CN1016175B/zh not_active Expired
- 1986-04-24 GB GB8610037A patent/GB2174987B/en not_active Expired
- 1986-04-24 SE SE8601907A patent/SE461468B/sv not_active IP Right Cessation
- 1986-04-24 NO NO861617A patent/NO163406C/no unknown
- 1986-04-24 SU SU864027355A patent/SU1450746A3/ru active
- 1986-04-24 CH CH1679/86A patent/CH675722A5/de not_active IP Right Cessation
- 1986-04-24 GR GR861086A patent/GR861086B/el unknown
- 1986-04-24 ES ES554336A patent/ES8708229A1/es not_active Expired
- 1986-04-24 LU LU86406A patent/LU86406A1/fr unknown
- 1986-04-24 DK DK190986A patent/DK164868C/da not_active IP Right Cessation
- 1986-04-24 PT PT82460A patent/PT82460B/pt not_active IP Right Cessation
- 1986-04-24 FR FR868605966A patent/FR2581065B1/fr not_active Expired - Fee Related
- 1986-04-24 IT IT8620206A patent/IT1215651B/it active
- 1986-04-24 NL NL8601053A patent/NL8601053A/xx not_active Application Discontinuation
- 1986-04-24 BE BE0/216585A patent/BE904671A/fr not_active IP Right Cessation
- 1986-04-25 KR KR1019860003204A patent/KR940000828B1/ko active IP Right Grant
- 1986-04-25 DE DE19863614132 patent/DE3614132A1/de not_active Ceased
- 1986-04-25 AT AT0112186A patent/AT390257B/de not_active IP Right Cessation
- 1986-04-25 HU HU861723A patent/HU195813B/hu not_active IP Right Cessation
- 1986-04-25 OA OA58845A patent/OA08242A/xx unknown
1987
- 1987-02-27 SU SU874202071A patent/SU1470192A3/ru active
- 1987-05-14 ES ES557551A patent/ES8801829A1/es not_active Expired
- 1987-05-14 ES ES557552A patent/ES8802521A1/es not_active Expired
- 1987-06-23 YU YU116787A patent/YU46054B/sh unknown
- 1987-09-25 SU SU874203391A patent/SU1560056A3/ru active
- 1987-09-29 MY MYPI87002266A patent/MY102086A/en unknown
1991
- 1991-04-30 DK DK080291A patent/DK165248C/da not_active IP Right Cessation
- 1991-05-01 DK DK081091A patent/DK165249C/da not_active IP Right Cessation
1992
- 1992-03-10 SG SG290/92A patent/SG29092G/en unknown
- 1992-08-27 HK HK644/92A patent/HK64492A/xx unknown
- 1992-11-06 CY CY1641A patent/CY1641A/xx unknown

Also Published As

Publication number	Publication date
HUT42089A (en)	1987-06-29
GB2174987A (en)	1986-11-19
LU86406A1 (fr)	1986-11-05
NO163406B (no)	1990-02-12
DK165249B (da)	1992-10-26
DK80291A (da)	1991-04-30
ATA112186A (de)	1989-09-15
CN86102747A (zh)	1987-02-04
FI861684A0 (fi)	1986-04-22
GB2174987B (en)	1989-08-02
YU46054B (sh)	1992-12-21
NL8601053A (nl)	1986-11-17
IL78581A0 (en)	1986-08-31
YU116787A (en)	1988-04-30
FR2581065A1 (fr)	1986-10-31
SU1450746A3 (ru)	1989-01-07
KR860008177A (ko)	1986-11-12
DK165248C (da)	1993-03-22
DK81091A (da)	1991-05-01
HK64492A (en)	1992-09-04
ES8802521A1 (es)	1988-07-16
IT8620206A0 (it)	1986-04-24
PT82460A (en)	1986-05-01
SU1560056A3 (ru)	1990-04-23
AT390257B (de)	1990-04-10
DK190986A (da)	1986-10-26
FI861684A (fi)	1986-10-26
FR2581065B1 (fr)	1990-02-02
BE904671A (fr)	1986-10-24
FI83316C (fi)	1991-06-25
DK80291D0 (da)	1991-04-30
SU1470192A3 (ru)	1989-03-30
OA08242A (en)	1987-10-30
DK165248B (da)	1992-10-26
NO163406C (no)	1990-05-23
ES557552A0 (es)	1988-07-16
IT1215651B (it)	1990-02-22
DK165249C (da)	1993-03-22
KR940000828B1 (ko)	1994-02-02
AU592983B2 (en)	1990-02-01
CN1016175B (zh)	1992-04-08
FI83316B (fi)	1991-03-15
SE8601907D0 (sv)	1986-04-24
NO861617L (no)	1986-10-27
ES8801829A1 (es)	1988-02-16
ES557551A0 (es)	1988-02-16
NZ215885A (en)	1989-04-26
ES8708229A1 (es)	1987-10-01
CY1641A (en)	1992-11-06
AU5641386A (en)	1986-10-30
ES554336A0 (es)	1987-10-01
CH675722A5 (fi)	1990-10-31
MY102086A (en)	1992-03-31
SG29092G (en)	1992-05-15
CA1298836C (en)	1992-04-14
HU195813B (en)	1988-07-28
DK81091D0 (da)	1991-05-01
DK164868C (da)	1993-01-11
DK190986D0 (da)	1986-04-24
PT82460B (pt)	1988-11-30
SE461468B (sv)	1990-02-19
SE8601907L (sv)	1986-10-26
DK164868B (da)	1992-08-31
GR861086B (en)	1986-09-01
US4668686A (en)	1987-05-26
DE3614132A1 (de)	1986-11-27
GB8610037D0 (en)	1986-05-29

Publication	Publication Date	Title
EG18104A (en)	1992-09-30	Imidazoquinoline antithrombogenic cardiotonic agent
GB8518300D0 (en)	1985-08-29	Contrast agent
GB8522535D0 (en)	1985-10-16	Contrast agent
IL78934A0 (en)	1986-09-30	Alfuzosine compositions and use
GB8612781D0 (en)	1986-07-02	Formulation
GB8612780D0 (en)	1986-07-02	Formulation
GB8600945D0 (en)	1986-02-19	Self-locking agent
AR243887A1 (es)	1993-09-30	Procedimiento para la preparacion de piridilcarbonil-tiazolonas cardiotonicas.
ZA863029B (en)	1986-12-30	Imidazoquinoline antithrombogenic cardiotonic agents
DE3665805D1 (en)	1989-11-02	Antimicrobial agent
ZA863645B (en)	1987-01-28	Yield-promoting agents
GB8513358D0 (en)	1985-07-03	Formulation
ZA867750B (en)	1987-06-24	Cardiotonic aroylthiazolones
PH23182A (en)	1989-05-29	Cardiotonic alkanoylthiazolones
GB8525013D0 (en)	1985-11-13	Antidiarrhoel agents
DE3662058D1 (en)	1989-03-16	Leather-treating agent and its use
GB8529500D0 (en)	1986-01-08	Formulation
IE861087L (en)	1986-10-15	Imidazoquinoline cardiotonic agent
BG40893A1 (en)	1987-03-14	Modifying agent
PL257182A1 (en)	1987-07-13	Coat-forming agent
PL254372A1 (en)	1987-04-21	Dishwashing agent
PL253439A3 (en)	1987-01-12	Corrosion preventing agent
IL80301A0 (en)	1987-01-30	Cardiotonic aroylthiazolones
ZA867749B (en)	1987-06-24	Cardiotonic aroylthiazolones
IE850585L (en)	1985-09-08	Benzisothiazoles-fungicidal agents